US Broker Ratings

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating Growth with a Strong 32% Revenue Increase

Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, has been capturing investor attention with its substantial growth trajectory. As..

Abbott Laboratories (ABT) Stock Analysis: Unveiling a 31% Potential Upside for Savvy Investors

Abbott Laboratories (NYSE: ABT), a venerable name in the healthcare sector, continues to be a compelling prospect for investors seeking both stability and growth. With its current market cap standing..

Bristol-Myers Squibb (BMY) Investor Outlook: A Look at Its 4.30% Dividend Yield and Growth Potential

For investors with an eye on the healthcare sector, Bristol-Myers Squibb Company (NYSE: BMY) presents a compelling case with its robust dividend yield and potential for growth. With a market..

Edwards Lifesciences Corporation (EW) Stock Analysis: Unveiling a 24% Potential Upside

Edwards Lifesciences Corporation (NYSE: EW), a leader in the medical devices industry, stands out in the healthcare sector with its innovative cardiovascular solutions. Headquartered in Irvine, California, the company has..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A Biotech Powerhouse with 15.19% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, offers investors an intriguing opportunity for growth. With a market capitalization of $11.96 billion, this Ireland-based company has..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a Potential 32.58% Upside for Investors

Bio-Techne Corp (NASDAQ: TECH) stands as a key player in the biotechnology sector, developing and manufacturing life science reagents, instruments, and services for global markets. With a market capitalization of..

Repligen Corporation (RGEN) Stock Analysis: Uncovering a 53% Potential Upside

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, is capturing the attention of investors with a significant potential upside..

Insulet Corporation (PODD) Stock Analysis: Strong Growth Potential with a 72.78% Upside

Insulet Corporation (NASDAQ: PODD), a prominent player in the healthcare sector, specializes in the development and sale of innovative insulin delivery systems. With a current market capitalization of $13.86 billion,..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Potential 31.89% Upside Amid Robust Revenue Growth

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a titan in the healthcare sector specializing in diagnostics and research, commands a significant presence in the veterinary diagnostics market. With a market capitalization of..

BioNTech SE (BNTX) Stock Analysis: Navigating a Complex Valuation with Promising Upside

BioNTech SE (NASDAQ: BNTX), a pioneer in the biotechnology space, has garnered significant attention for its role in developing mRNA-based therapies. With a market capitalization of $24.15 billion, this German..

IQVIA Holdings, Inc. (IQV) Investor Outlook: Analyzing a 38.79% Potential Upside

IQVIA Holdings, Inc. (NYSE: IQV), a prominent player in the healthcare sector, continues to capture investor attention with its extensive portfolio of clinical research services and healthcare intelligence solutions. The..

Regeneron Pharmaceuticals (REGN) Investor Outlook: Analyzing the 16.90% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a prominent player in the biotechnology sector, has consistently positioned itself as a leader in the healthcare industry with its innovative treatments and robust pipeline...

argenx SE (ARGX) Investor Outlook: Navigating a Promising 28.89% Upside in Biotech

argenx SE (ARGX), a leading name in the biotechnology sector, is captivating investor attention with its robust market presence and promising growth prospects. Headquartered in the Netherlands, this commercial-stage biopharma..

Elevance Health, Inc. (ELV) Stock Analysis: A 22% Upside Potential Amidst Solid Revenue Growth

Elevance Health, Inc. (NYSE: ELV), a stalwart in the healthcare sector, is currently drawing attention from the investment community. With a market capitalization of $68.76 billion, Elevance operates a broad..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unveiling a Promising 82.86% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN), a key player in the medical instruments and supplies industry, is turning heads among investors with a compelling 82.86% potential upside. With a market capitalization..

AptarGroup, Inc. (ATR) Stock Analysis: Unlocking a 23.74% Potential Upside in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR), a leader in the medical instruments and supplies industry, presents an enticing opportunity for investors looking for stable growth and reliable dividends within the healthcare sector...

Bio-Rad Laboratories, Inc. (BIO) Stock Report: Navigating Healthcare Innovation with an 8.33% Upside Potential

Investors with a keen eye on the healthcare sector may find Bio-Rad Laboratories, Inc. (NYSE: BIO) an intriguing prospect. With a market capitalization of $7.54 billion, this Hercules, California-based company..

Eli Lilly and Company (LLY)

⚠️ No article content returned.

..

AstraZeneca PLC (AZN) Stock Analysis: Navigating Growth and a Strategic Edge in Healthcare

AstraZeneca PLC (NASDAQ: AZN), a leading entity in the healthcare sector, is making waves with its robust market position and strategic advancements in the biopharmaceutical industry. Currently boasting a market..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Strong Buy Ratings and 23.89% Upside Potential

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), an established giant in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth metrics. As a leading..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds